The legacy success of copyright’s flagship drug has undeniably influenced the drug landscape. However, putting money in companies heavily reliant on copycat drugs and the diminishing patent protection https://bookmarkindexing.com/story21262991/the-blue-pill-and-pharma-a-uncertain-opportunity